{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:21:14Z","timestamp":1743826874594,"version":"3.40.3"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":406,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["#AID-OAA-A-11-00051"],"award-info":[{"award-number":["#AID-OAA-A-11-00051"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R56 AI108368-01"],"award-info":[{"award-number":["1 R56 AI108368-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development (USAID)","doi-asserted-by":"crossref","award":["AID-OAA-A-11-00051"],"award-info":[{"award-number":["AID-OAA-A-11-00051"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R56 AI108368-01"],"award-info":[{"award-number":["1 R56 AI108368-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["#AID-OAA-A-11-00051"],"award-info":[{"award-number":["#AID-OAA-A-11-00051"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R56 AI108368-01"],"award-info":[{"award-number":["1 R56 AI108368-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ijgo.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Multipurpose prevention technologies (MPTs) designed to simultaneously prevent pregnancy and HIV could provide urgently needed tools to address unmet sexual and reproductive health needs of women worldwide. Late\u2010stage clinical trials will be complex given the need to demonstrate efficacy for HIV and contraceptive indications simultaneously from a single product. Currently, HIV and pregnancy prevention trials have distinctive design features that will need to be reconciled in MPT trials. This article identifies several ethical issues uniquely associated with this research that will benefit from future deliberation and guidance to ensure that this globally important research can proceed efficiently and expeditiously.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.ijgo.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T23:46:25Z","timestamp":1406072785000},"page":"221-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ethical issues for late\u2010stage trials of multipurpose prevention technologies for HIV and pregnancy"],"prefix":"10.1002","volume":"127","author":[{"given":"Jessica A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna C.","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"790154","article-title":"Developing multipurpose reproductive health strategies: an integrated strategy","author":"Harrison P.F.","year":"2013","journal-title":"AIDS Res Treat"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.11.009"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.08.002"},{"key":"e_1_2_9_5_2","unstructured":"CONRAD Product development.http:\/\/www.conrad.org\/microbicides\u2010development.html Accessed March 18 2014"},{"volume-title":"Ethical considerations in HIV preventive vaccine research","year":"2000","author":"UNAIDS","key":"e_1_2_9_6_2"},{"key":"e_1_2_9_7_2","unstructured":"RennieS. SugarmanJ. HPTN Ethics Working Group HIV Prevention Trials Network (HPTN) Ethics Guidance for Research.http:\/\/www.hptn.org\/web%20documents\/EWG\/HPTNEthicsGuidanceV10Jun2009.pdf 2009 Accessed September 10 2013"},{"volume-title":"Ethical considerations in biomedical HIV prevention trials UNAIDS\/WHO Guidance Document","year":"2012","author":"UNAIDS","key":"e_1_2_9_8_2"},{"volume-title":"Guideline on clinical investigation of steroid contraceptives in women","year":"2005","author":"European Medicines Agency","key":"e_1_2_9_9_2"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.31899\/hiv1.1011"},{"issue":"3","key":"e_1_2_9_11_2","article-title":"Unmet need for contraceptives in developing world has declined, but remains high in some countries [Digest]","volume":"39","author":"Guttmacher Institute","year":"2013","journal-title":"Int Perspect Sex Reprod Health"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.08.018"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.COH.0000410238.80894.81"},{"key":"e_1_2_9_14_2","unstructured":"Microbicides Trials Network (MTN) Drug resistance and ARV\u2010based prevention fact sheet.http:\/\/www.mtnstopshiv.org\/news\/studies\/mtn003\/drfactsSeptember2010 Accessed March 24 2014"},{"key":"e_1_2_9_15_2","unstructured":"Microbicides Trials Network (MTN) MTN\u2010020 web page.http:\/\/www.mtnstopshiv.org\/studies\/3614 Accessed September 5 2013"},{"key":"e_1_2_9_16_2","unstructured":"BirnkrantD.Critical issues in Phase 2b and 3 trials: Special populations Presented at: World Health Organization symposium. May 22 2010 Pittsburgh PA USA"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60257-7"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.2979\/intjfemappbio.4.2.124"},{"key":"e_1_2_9_19_2","unstructured":"Microbicides Trials Network (MTN) MTN\u2010008 web page.http:\/\/www.mtnstopshiv.org\/studies\/1637 Accessed September 5 2013"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12210"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70155-5"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000036"},{"key":"e_1_2_9_23_2","unstructured":"USAID PEPFAR. Technical Brief: Hormonal Contraception and HIV.http:\/\/www.usaid.gov\/sites\/default\/files\/documents\/1864\/hormonal\u2010contraception\u2010and\u2010HIV.pdfSeptember2013 Accessed March 24 2014"},{"key":"e_1_2_9_24_2","doi-asserted-by":"crossref","unstructured":"MacklinR.Intertwining biomedical research and public health in HIV microbicide research Public Health Ethics.2010;1\u201311","DOI":"10.1093\/phe\/phq019"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2012-100936"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.2307\/3528248"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2010.037176"},{"volume-title":"Standards of prevention in HIV prevention trials: Consultation report and recommendations","year":"2010","author":"McGroy E.","key":"e_1_2_9_28_2"},{"volume-title":"Mapping the standard of care at microbicide clinical trial sites","year":"2008","author":"Heise L.","key":"e_1_2_9_29_2"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1525\/jer.2008.3.4.5"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729214003713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729214003713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2014.07.012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2014.07.012","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ijgo.2014.07.012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.ijgo.2014.07.012","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ijgo.2014.07.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T19:13:53Z","timestamp":1743794033000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1016\/j.ijgo.2014.07.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1016\/j.ijgo.2014.07.012"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgo.2014.07.012","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"type":"print","value":"0020-7292"},{"type":"electronic","value":"1879-3479"}],"subject":[],"published":{"date-parts":[[2014,7,22]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecology & Obstetrics","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.ijgo.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}